RW
Therapeutic Areas
Snyder Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oral L-DOPA/Carbidopa | Adjunctive Treatment for Neovascular Age-Related Macular Degeneration (nAMD) | Proof-of-Concept |
| Drug | Indication | Phase |
|---|---|---|
| Oral L-DOPA/Carbidopa | Adjunctive Treatment for Neovascular Age-Related Macular Degeneration (nAMD) | Proof-of-Concept |